-
admin
Posts
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
Galera’s development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer. Lead program...
Burning Rock Announces Results of 2024 Annual General Meeting
GUANGZHOU, China, Dec. 31, 2024 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application...
Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study
Further secures Brii’s rights in BRII-179 with full control of intellectual property, future manufacturing and supply Several combination treatment studies containing BRII-179 have quickly started...
Empowering Malaysia’s future: FWD Insurance and BSN’s Camp Millionaire champions financial literacy
Nationwide initiative culminates in a transformative financial education camp, equipping primary school students with essential financial management skills and fostering a financially inclusive Malaysia. KUALA...
Sinopec Releases First Sustainable Development Report in Algeria
ALGIERS, Algeria, Dec. 31, 2024 /PRNewswire/ — China Petroleum & Chemical Corporation (HKG: 0386, “Sinopec”) has officially released the first sustainability report, Sustainability Report on Serving...
Beijing Review: Gold Rush 2.0? Unpacking the glowing trends among China’s youth
BEIJING, Dec. 31, 2024 /PRNewswire/ — From crafting their own pieces to collecting beads and beans, a gold fever has taken over China’s younger generations....
New Oriental to Report Second Quarter 2025 Financial Results on January 21, 2025
BEIJING, Dec. 31, 2024 /PRNewswire/ — New Oriental Education and Technology Group Inc. (the “Company” or “New Oriental”) (NYSE: EDU/ 9901.SEHK), a provider of private...
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
Wuxi, China, Dec. 30, 2024 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd. (Nasdaq: PHH) (the “Company”), a company focused on developing private skincare...
ARCPOINT REACHES AGREEMENT TO SELL 68% OWNERSHIP STAKE IN NON-CORE ASSET
Greenville, South Carolina, Dec. 30, 2024 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) reports that it has entered into an agreement...
FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus...
